Phenolic compounds from plants as nitric oxide production inhibitors

Current Medicinal Chemistry

Volumn 18, Issue 8, 2011, Pages 1137-1145

  Conforti, F ^a   Menichini, F ^a  

^a UNIVERSITY OF CALABRIA   (Italy)

Author keywords

Flavonoide; Nitric oxide; Phenolic compounds; Stilbenes

Indexed keywords

(6) GINGEROL; APIGENIN; BAICALEIN; BAICALIN; DAIDZEIN; FLAVAN DERIVATIVE; FLAVONOID; FLAVONOL DERIVATIVE; GENISTEIN; GLYCITEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; ISOFLAVONE DERIVATIVE; ISOLIQUIRITIGENIN; ISOVITEXIN; LUTEOLIN; NITRIC OXIDE; PHENOL DERIVATIVE; PTEROSTILBENE; REACTIVE OXYGEN METABOLITE; RESVERATROL; UNCLASSIFIED DRUG; WOGONIN;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER PREVENTION; CHRONIC DISEASE; COLON CANCER; CONCENTRATION RESPONSE; CYTOKINE RELEASE; DRUG BIOAVAILABILITY; DRUG CYTOTOXICITY; DRUG STRUCTURE; HUMAN; IC 50; INFLAMMATION; NONHUMAN; NUTRITIONAL VALUE; OXIDATIVE STRESS; PLASMA CLEARANCE; PROSTAGLANDIN SYNTHESIS INHIBITION; STRUCTURE ACTIVITY RELATION;

ANIMALS; HUMANS; NITRIC OXIDE; PHENOLS; PLANTS; REACTIVE OXYGEN SPECIES;

EID: 79952812731     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986711795029690     Document Type: Article

References (64)

1. Drew, B.; Leeuwenburgh, C. Aging and the role of reactive nitrogen species. Ann. N. Y. Acad. Sci., 2002, 959, 66-81. (Pubitemid 34457553)
2. Olanow, C.W.; Tatton, W.G. Etiology and pathogenesis of Parkinson's disease. Annu. Rev. Neurosci., 1999, 22, 123-44. (Pubitemid 29144883)
3. Giulian, D. Microglia and the immune pathology of Alzheimer disease. Am. J. Hum. Genet., 1999, 65, 13-8. (Pubitemid 30470443)
4. Liu, B.; Hong, J.S. Role of microglia in inflammation-mediated neurodegenerative diseases: Mechanism and strategies for therapeutic intervention. J. Pharmacol. Exp. Ther., 2003, 304, 1-7. (Pubitemid 36008905)
5. Wang, X.J.; Chen, S.D.; Ma, G.Z.; Ye, M.; Lu, G.Q. Involvement of proinflammatory factors, apoptosis, caspase-3 activation and Ca2+ disturbante in microglia activation-mediated dopaminergic cell degeneration. Mech. Ageing Dev., 2005, 126, 1241-54. (Pubitemid 41572241)
6. Wang, X.J.; Yan, Z.Q.; Lu, G.Q.; Stuart, S.; Chen, S.D. Parkinson disease IgG and C5a-induced synergistic dopaminergic neurotoxicity: Role of microglia. Neurochem. Int., 2007, 50, 39-50. (Pubitemid 44895357)
7. Gao, H.M.; Hong, J.S.; Zhang,W.Q.; Liu, B. Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons. J. Neurosci., 2002, 22, 782-90. (Pubitemid 34141759)
8. Gayle, D.A.; Ling, Z.; Tong, C.; Landers, T.; Lipton, J.W.; Carvey, P.M. Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: Roles of tumor necrosis factor-α, interleukin-1β and nitric oxide. Brain Res. Dev. Brain Res., 2002, 133, 27-35. (Pubitemid 34146496)
9. Kim, W.G.; Mohney, R.P.; Wilson, B.; Jeohn, G.H.; Liu, B.; Hong, J.S. Regional difference in the susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: Role of microglia. J. Neurosci., 2000, 20, 6309-16. (Pubitemid 30658427)
10. Liu, B.; Du, L. ; Hong, J.S. Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation. J. Pharmacol. Exp. Ther., 2000, 293, 607-17. (Pubitemid 30244114)
11. Liu, B.; Gao, H.M.; Wang, J.Y.; Jeohn, G.H.; Cooper, C.L.; Hong, J.S. Role of nitric oxide in inflammation-mediated neurodegeneration. Ann. N.Y. Acad. Sci., 2002, 962, 256-63.
12. Iadecola, C. Dark and bright sides of nitric oxide in ischemic brain injury. Trends Neurosci., 1997, 20, 132-9. (Pubitemid 27086729)
13. Groenendaal, F.; Mishra, O.P.; McGowan, J.E.; Hoffman, D.J.; Delivoria- Papadopoulos, M. Cytosolic and membrane-bound cerebral nitric oxide synthase activity during hypoxia in cortical tissue of newborn piglets. Neurosci. Lett., 1996, 206, 121-4. (Pubitemid 26094676)
14. Jiang, K.; Kim, S.; Murphy, S.; Song, D.; Pastuszko, A. Effect of hypoxia and reoxygenation on regional activity of nitric oxide synthase in brain of newborn piglets. Neurosci. Lett., 1996, 206, 199-203. (Pubitemid 26094693)
15. Yamamoto, T.; Sawada, Y.; Katayama, I.; Nishioka, K. Increased production of nitric oxide stimulated by interleukin-1 in peripheral blood mononuclear cells in patients with systemic sclerosis. Br. J. Rheumatol., 1998, 37, 1123-5.
16. Arkovitz, M.S.; Wispé, J.R.; Garcia, V.F.; Szabó, C. Massive pumonary haemorrhage caused by leptospirosis successfully treated with nitric oxide inhalation and haemofiltration. J. Pediatr. Surg., 1996, 31, 1009-15.
17. Shan, Q.; Bourreau, J.P. Cardiac and vascular effects of nitric oxide synthase inhibition in lipopolysaccharide-treated rats. Eur. J. Pharmacol., 2000, 406, 257-64.
18. Perazzolli, M.; Romero-Puertas, M.C.; Delledonne, M. Modulation of nitric oxide bioactivity by plant haemoglobins. J. Exp. Bot., 2006, 57, 479-88. (Pubitemid 43164379)
19. Bravo, L. Polyphenols: Chemistry, dietary sources, metabolism, and nutritional significance. Nutr. Rev., 1998, 56, 317-33. (Pubitemid 28532456)
20. Eastwood, M.A. Interaction of dietary antioxidants in vivo: How fruit and vegetables prevent disease? Q. J. Med., 1999, 92, 527-30. (Pubitemid 29430051)
21. Harborne, J.B. Plant phenolics, Bell E.A., Charlwood B.V., (Ed.) Encyclopedia of plant physiology, secondary plant products, Springer-Verlag: Berlin, 1980, Vol. 8, pp. 329-95.
22. Das, N.P.; Griffiths, L.A. Studies on flavonoid metabolism. Metabolism of (+)- [14C] catechin in the rat and guinea pig. Biochem. J., 1969, 115, 831-6.
23. Williams, R.J.; Spencer, J.P.; Rice-Evans, C. Flavonoids: Antioxidants or signalling molecules? Free Radic. Biol. Med., 2004, 36, 838-49. (Pubitemid 38352901)
24. Jang, M.; Cai, L.; Udeani, G.O.; Slowing, K.V.; Thomas, C.F.; Beecher, C.W.; Fong, H.H.; Farnsworth, N.R.; Kinghorn, A.D.; Mehta, R.G.; Moon, R.C.; Pezzuto, J.M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science, 1997, 275, 218-20. (Pubitemid 127696281)
25. Kimura, Y.; Okuda, H.; Arichi, S. Effects of stilbenes on arachidonate metabolism in leukocytes. Biochimica et Biophysica Acta, 1985, 834, 275-8. (Pubitemid 15072791)
26. Subbaramaiah, K.; Chung, W.J.; Michaluart, P.; Telang, N.; Tanabe, T.; Inoue, H.; Jang, M.; Pezzuto, J.M.; Dannenberg, A.J. Resveratrol inhibits cyclooxygenase- 2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J. Biol. Chem., 1998, 273, 21875-82. (Pubitemid 28405365)
27. Kimura, Y.; Okuda, H.; Kubo, M. Effects of stilbenes isolated from medicinal plants on arachidonate metabolism and degranulation in human polymorphonuclear leukocytes". J. Ethnopharmacol., 1995, 45, 131-9.
28. El-Mowafy, A.M.; White, R.E. Resveratrol inhibits MAPK activity and nuclear translocation in coronary artery smooth muscle: Reversal of endothelin- 1 stimulatory effects. FEBS Lett., 1999, 451, 63-7. (Pubitemid 29236173)
29. Kawada, N.; Seki, S.; Inoue, M.; Kuroki, T. Effect of antioxidants, resveratrol, quercetin, and N-acetylcysteine, on the functions of cultured rat hepatic stellate cells and Kupffer cells. Hepatology, 1998, 27, 1265-74. (Pubitemid 28227853)
30. Stewart, J.R.; Ward, N.E.; Ioannides, C.G.; O'Brian, C.A. Resveratrol preferentially inhibits protein kinase C-catalyzed phosphorylation of a cofactorindependent, arginine-rich protein substrate by a novel mechanism. Biochemistry, 1999, 38, 13244-51.
31. Cheong, H.; Ryu, S.Y.; Kim, K.M. Anti-allergic action of resveratrol and related hydroxystilbenes. Planta Med., 1999, 65, 266-8. (Pubitemid 29186086)
32. Tsai, S.H.; Lin-Shiau, S.Y.; Lin, J.K. Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol. Br. J. Pharmacol., 1999, 126, 673-80.
33. Matsuda, H.; Kageura, T.; Morikawa, T.; Toguchida, L.; Harima, S.; Yoshikawa, M. Effects of stilbene constituents from rhubarb on nitric oxide production in lipopolysaccharide-activated macrophages. Bioorg. Med. Chem. Lett., 2000, 10, 323-7. (Pubitemid 30125181)
34. Wadsworth, T.L.; Koop, D.R. Effects of the wine polyphenolics quercetin and resveratrol on pro-inflammatory cytokine expression in RAW 264.7 macrophages. Biochem. Pharmacol., 1999, 57, 941-9. (Pubitemid 29127108)
35. De la Lastra, C.A.; Villegas, I. Resveratrol as an anti-inflammatory and antiaging agent: Mechanisms and clinical implications. Mol. Nutr. Food Res., 2005, 49, 405-30. (Pubitemid 40780389)
36. Mgbonyebi, O.P.; Russo, J.; Russo, I.H. Antiproliferative effect of synthetic resveratrol on human breast epithelial cells. Int. J. Oncol., 1998, 12, 865-9. (Pubitemid 28133580)
37. Gehm, B.D.; McAndrews, J.M.; Chien, P.Y.; Jameson, J.L. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc. Natl. Acad. Sci. U.S.A., 1997, 94, 14138-43. (Pubitemid 28009723)
38. Chen, C.K.; Pace-Asciak, C.R. Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta. Gen. Pharmacol., 1996, 27, 363-6. (Pubitemid 26129194)
39. Hayashi, T.; Yamada, K.; Esaki, T.; Muto, E.; Chaudhuri, G.; Iguchi, A. Physiological concentrations of 17 β-estradiol inhibit the synthesis of nitric oxide synthase in macrophages via a receptor-mediated system. J. Cardiovasc. Pharmacol., 1998, 31, 292-8. (Pubitemid 28099171)
40. Hunt, J.S.; Miller, L.; Platt, J.S. Hormonal regulation of uterine macrophages. Develop. Immunol., 1998, 6, 105-10. (Pubitemid 28409870)
41. Cheong, H.; Ryu, S.Y.; Oak, M.H.; Cheon, S.H.; Yoo, G.S.; Kim, K.M. Studies of structure activity relationship of flavonoids for the anti-allergic actions. Arch. Pharm. Res., 1998, 21, 478-80. (Pubitemid 128661839)
42. Cho, D.I.; Koo, N.Y.; Chung, W.J.; Kim, T.S.; Ryu, S.Y.; Im, S.Y.; Kim, K.M. Effects of resveratrol-related hydroxystilbenes on the nitric oxide production in macrophage cells: Structural requirements and mechanism of action. Life Sci., 2002, 71, 2071-82.
43. Walker, G.; Pfeilschifter, J.; Kunz, D. Mechanisms of suppression of inducible nitric-oxide synthase (iNOS) expression in interferon (IFN)-gammastimulated RAW 264.7 cells by dexamethasone. Evidence for glucocorticoidinduced degradation of iNOS protein by calpain as a key step in posttranscriptional regulation. J. Biol. Chem., 1997, 272, 16679-87. (Pubitemid 27276502)
44. Suh, N.; Paul, S.; Hao, X.; Simi, B.; Xiao, H.; Rimando, A.M.; Reddy, B.S. Pterostilbene, an active constituent of blueberries, suppresses aberrant crypt foci formation in the azoxymethane-induced colon carcinogenesis model in rats. Clin. Cancer Res., 2007, 13, 350-5. (Pubitemid 46121889)
45. Ippoushi, K.; Azuma, K.; Ito, H.; Horie, H.; Higashio, H. [6]-Gingerol inhibits nitric oxide synthesis in activated J774.1 mouse macrophages and prevents peroxynitrite-induced oxidation and nitration reactions. Life Sci., 2003, 73, 3427-37. (Pubitemid 37311382)
46. Jacobsen, J.S.; Reinhart, P.; Pangalos, M.N. Current concepts in therapeutic strategies targeting cognitive decline and disease modification in Alzheimer's disease. NeuroRx, 2005, 2, 612-26. (Pubitemid 41393269)
47. Lin, C.M.; Huang, S.T.; Liang, Y.C.; Lin, M.S.; Shih, C.M.; Chang, Y.C.; Chen, T.Y.; Chen, C.T. Isovitexin suppresses lipopolysaccharide-mediated inducible nitric oxide synthase through inhibition of NF-kappa B in mouse macrophages. Planta Med., 2005, 71, 748-53.
48. Conforti, F.; Rigano, D.; Menichini, F.; Loizzo, M.R.; Senatore, F. Protection against neurodegenerative diseases of Iris pseudopumila extracts and their constituents. Fitoterapia, 2009, 80, 62-7.
49. Chen H.Q.; Jin, Z.Y.; Wang, X.J.; Xu, X.M.; Deng, L.; Zhao, J.W. Luteolin protects dopaminergic neurons from inflammation-induced injury through inhibition of microglial activation. Neurosci. Lett., 2008, 448, 175-9.
50. Kim, H.K.; Cheon, B.S.; Kim, Y.H.; Kim, S.Y.; Kim, H.P. Effects of naturally occurring flavonoids on nitric oxide production in the macrophage cell line RAW 264.7 and their structure-activity relationships. Biochem. Pharmacol., 1999, 58, 759-65. (Pubitemid 29329524)
51. Chi, Y.S.; Cheon, B.S.; Kim, H.P. Effect of wogonin, a plant flavone from Scutellaria radix, on the suppression of cyclooxygenase-2 and the induction of inducible nitric oxide synthase in lipopolysaccharide-treated RAW 264.7 cells. Biochem. Pharmacol., 2001, 61, 1195-203.
52. Shen, S.C.; Lee, W.R.; Lin, H.Y.; Huang, H.C.; Ko, C.H.; Yang, L.L.; Chen, Y.C. In vitro and in vivo inhibitory activities of rutin, wogonin, and quercetin on lipopolysaccharide-induced nitric oxide and prostaglandin E(2) production. Eur. J. Pharmacol., 2002, 446, 187-94.
53. Chen, Y.C.; Shen, S.C.; Chen, L.G.; Lee, T.J.; Yang, L.L. Wogonin, baicalin, and baicalein inhibition of inducible nitric oxide synthase and cyclooxygenase- 2 gene expressions induced by nitric oxide synthase inhibitors and lipopolysaccharide. Biochem. Pharmacol., 2001, 61, 1417-27. (Pubitemid 32452358)
54. Chen, H.Q.; Jin, Z.Y.; Li, G.H. Biochanin A protects dopaminergic neurons against lipopolysaccharide-induced damage through inhibition of microglia activation and proinflammatory factors generation. Neurosci. Lett., 2007, 417, 112-7.
55. Chen, H.Q.; Wang, X.J.; Jin, Z.Y.; Xu, X.M.; Zhao, J.W.; Xie, Z.J. Protective effect of isoflavones from Trifolium pratense on dopaminergic neurons. Neurosci. Res., 2008, 62, 123-30.
56. Jun, M.; Hong, J.; Jeong, W.S.; Ho, C.T. Suppression of arachidonic acid metabolism and nitric oxide formation by kudzu isoflavones in murine macrophages. Mol. Nutr. Food Res., 2005, 49, 1154-9. (Pubitemid 43004348)
57. Sheu, F.; Lai, H.H. ; Yen, G.C. Suppression effect of soy isoflavones on nitric oxide production in RAW 264.7 macrophages. J. Agric. Food Chem., 2001, 49, 1767-72. (Pubitemid 32816817)
58. Scuro, L.S.; Simioni, P.U.; Grabriel, D.L.; Saviani, E.E.; Modolo, L.V.; Tamashiro, W.M.; Salgado, I. Suppression of nitric oxide production in mouse macrophages by soybean flavonoids accumulated in response to nitroprusside and fungal elicitation. BMC Biochem., 2004, 21, 5:5.
59. Ryu, J.H.; Ahn, H.; Jin, L.H. Inhibition of nitric oxide production on LPSactivated macrophages by kazinol B from Broussonetia kazinoki. Fitoterapia, 2003, 74, 350-4. (Pubitemid 36623297)
60. Kim, J.Y.; Park, S.J.; Yun, K.J.; Cho, Y.W.; Park, H.J.; Lee, K.T. Isoliquiritigenin isolated from the roots of Glycyrrhiza uralensis inhibits LPS-induced iNOS and COX-2 expression via the attenuation of NF-kappaB in RAW 264.7 macrophages. Eur. J. Pharmacol., 2008, 584, 175-84.
61. Mimica-Dukic, N.; Simin, N.; Cvejic, J.; Jovin, E.; Orcic, D.; Bozin, B. Phenolic compounds in field horsetail (Equisetum arvense L.) as natural antioxidants. Molecules, 2008 13, 1455-64.
62. Okoko, T.; Oruambo, I.F. Inhibitory activity of quercetin and its metabolite on lipopolysaccharide-induced activation of macrophage U937 cells. Food Chem. Toxicol., 2009, 47, 809-12.
63. Lee-Hitz, Y.Y.; Boerboom, A.J.; Westphal, A.H.; van-Berkel, W.J.; Aarts, J.M.; Reirjens, I.M. Pro-oxidant activity of flavonoids induces EpREmediated gene expression. Chem. Res. Toxicol., 2006, 19, 1499-505. (Pubitemid 44863492)
64. Autore, G.; Rastrelli, L.; Lauro, M.R.; Marzocco, S.; Sorrentino, R.; Sorrentino, U.; Pinto, A.; Aquino, R. Inhibition of nitric oxide synthase expression by a methanolic extract of Crescentia alata and its derived flavonols. Life Sci., 2001, 70, 523-34. (Pubitemid 34066520)